Hypothalamic astrocytes respond to transforming growth factor-α with the secretion of neuroactive substances that stimulate the release of luteinizing hormone-releasing hormone

• Published in: Endocrinology (Philadelphia) Vol. 138; no. 1; pp. 19 - 25
• Main Authors: MA, Y. J, BERG VON DER EMDE, K, RAGE, F, WETSEL, W. C, OJEDA, S. R
• Format: Journal Article
• Language: English
• Published: Bethesda, MD Endocrine Society 1997
• Subjects: Animals; Arachidonic Acid - metabolism; Astrocytes - drug effects; Astrocytes - secretion; Biological and medical sciences; Development. Senescence. Regeneration. Transplantation; Dinoprostone - physiology; Female; Fundamental and applied biological sciences. Psychology; Gonadotropin-Releasing Hormone - secretion; Hypothalamus - drug effects; Hypothalamus - secretion; Pregnancy; Rats; Rats, Sprague-Dawley; Receptor, Epidermal Growth Factor - physiology; Signal Transduction; Transforming Growth Factor alpha - pharmacology; Vertebrates: nervous system and sense organs; Cell culture; Rat; Peptide hormone; Rodentia; Cell biology; Gonadotropin RH; Prostaglandin E2; Neuroendocrine regulation; Astrocyte; Hypothalamus; In vitro; Hypothalamic hormone; Vertebrata; Mammalia; Animal; Hormonal regulation; Development; Transforming growth factor α; Hormone releasing factor
• ISSN: 0013-7227; 1945-7170
• DOI: 10.1210/en.138.1.19

Previous studies demonstrated the involvement of transforming growth factor-alpha (TGF alpha), a member of the epidermal growth factor (EGF) family, in the developmental regulation of hypothalamic LHRH release. Although both TGF alpha and EGF stimulate LHRH release, they do not appear to act directly on LHRH neurons, as no EGF/TGF alpha receptors are detected on these cells in vivo. Instead, the stimulatory effect of TGF alpha on LHRH release seems to require a glial intermediacy. The present study identifies one of the glial molecules involved in this process. In vitro exposure of purified hypothalamic astrocytes to TGF alpha or EGF in a defined medium led to activation of the cyclooxygenase-mediated pathway of arachidonic acid metabolism, as indicated by an increase in PGE2 release, but failed to affect lipooxygenase-mediated metabolism, as assessed by the lack of increase in leukotriene C4 production; addition of TGF alpha- (T-CM) or EGF-conditioned medium to cultures of LHRH-producing GT1-1 cells stimulated LHRH release. In contrast, direct exposure of GT1-1 cells to the growth factors was ineffective. Incubation of the cells in medium conditioned by untreated astrocytes (CM) was also ineffective. Blockade of either EGF receptor signal transduction or cyclooxygenase activity in the astrocytic cultures prevented both TGF alpha-induced PGE2 formation in astrocytes and the stimulatory effect of T-CM on LHRH release. Immunoneutralization of PGE2 actions or selective removal of the PG from T-CM also prevented T-CM-induced LHRH release. Addition of exogenous PGE2 restored the effect. Thus, PGE2 is one of the glial molecules involved in mediating the stimulatory effect of TGF alpha on LHRH release. The effectiveness of PGE2 in eliciting LHRH release was, however, greatly reduced when PG was delivered to GT1-1 cells in astrocyte-defined medium instead of CM. Thus, astrocytes appear to produce a yet to be identified substance(s) that facilitates the stimulatory effect of PGE2 on LHRH output. We postulate that the ability of TGF alpha to enhance LHRH release depends on the potentiating interaction of PGE2 with these additional glial-derived molecules.